Hematology-Oncology Associates of the Quad-Cities, PC
Myeloma Trials
E1A06An Intergroup Phase III Randomized Controlled Trial Comparing Melphalan, Prednisone and Thalidomide (MPT) Versus Melphalan, Prednisone and Lenalidomide (Revlimid(tm) (MPR) in Newly Diagnosed Multiple Myeloma Patients Who Are Not Candidates for High-Dose Therapy.
Connect MM: The Multiple Myeloma Disease Registry
Connect MM: The Multiple Myeloma Disease Registry
